Home/Pipeline/Sleep Apnea Biomarker Services

Sleep Apnea Biomarker Services

Obstructive Sleep Apnea (OSA)

Service OfferingActive

Key Facts

Indication

Obstructive Sleep Apnea (OSA)

Phase

Service Offering

Status

Active

Company

The Siesta Group

About The Siesta Group

The Siesta Group is a Vienna-based, neuroscience-focused service provider that empowers CNS drug development through advanced analysis of EEG, sleep, and activity data. Leveraging over 20 years of experience, proprietary AI-powered analysis tools, and a strong scientific network, the company helps sponsors identify biomarkers and endpoints for conditions ranging from sleep disorders to neurodegenerative diseases. It operates as a trusted partner to over 30 leading sponsors and CROs, offering a full suite of clinical trial services from feasibility to data visualization, all while maintaining rigorous compliance standards.

View full company profile

Therapeutic Areas

Sleep Disorders Sleep Apnea Neurodegenerative Diseases Mood Disorders Schizophrenia Autism Anxiety Disorders

Other Obstructive Sleep Apnea (OSA) Drugs

Drug	Company	Phase	Status
SCI-110	SciSparc	Preclinical	Exploratory
Inspire 4.0 / Next-Gen System	Inspire Medical Systems	Development	Active
DeltaWave CPAP Nasal Pillow System	Remsleep	Commercial	Active
AD109	Apnimed	Phase 3	Active
Injectable Neurostimulation System	Invicta Medical	Proof-of-Concept	Active
IHL-42X	Incannex Healthcare	Phase 2/3	Active - Pivotal trial ongoing